Category Archives: Health

What is new in the field of Health. Trending topics, and cutting edge research in the are of Health. Press Releases that give us updates on Health.

The 11th Annual Lake Nona Impact Forum Returns to Address Health Innovation in the New Reality


Dr. Sanjay Gupta speaking at the 2022 Lake Nona Impact Forum in Lake Nona, Orlando, Florida.

“Since its inception 11 years ago, Lake Nona Impact Forum’s North Star is to inspire human potential through health and wellbeing innovation,” said Impact Forum Founder Gloria Caulfield. “Our long-term goal is to be an incubator that accelerates innovation and sparks global change.”

Founded to address global issues and make an impact on health innovation, the annual Lake Nona Impact Forum will unite the foremost global thought leaders in health, wellbeing, technology and business from March 8–10, 2023. The event will feature in-depth, collaborative discussions about health innovation in the new reality. With a list of notable thought leaders from across the health spectrum including Dr. Chelsea Clinton, Dr. Rachel Levine, Paul Stamets and Dr. Sanjay Gupta, the invite-only event is hosted annually in the visionary community of Lake Nona located in Orlando. A mecca for health and wellbeing innovation, Lake Nona is home to some of the nation’s top universities, hospitals and research institutions where internationally acclaimed healthcare experts have launched businesses and pioneered first-of-its-kind advancements in their fields.

During a time in which the $4.4 trillion health and wellness industry continues to prove its importance in everyday life, heightened by exponential innovation during and following the COVID-19 pandemic, the Lake Nona Impact Forum brings together hundreds of diverse leaders and experts committed to improving human health on a global scale with a mission of developing and discussing long-term strategies that will catalyze the industry worldwide.

Coinciding with and celebrating International Women’s Day (March 8), prolific leaders will be speaking about equity for women in business and featured prominently throughout the three-day event including CVS Health President and Chief Executive Officer Karen Lynch, who was recently named the most inspirational CEO on the Fortune 500 list; Harvard T.H. Chan School of Public Health Assistant Professor of Immunology and Infectious Disease Dr. Kizzmekia Corbett, whose NIH team co-designed the leading COVID-19 vaccine mRNA-1273; Academy Award winning actor Geena Davis; and Organamet Bio CEO Doris Taylor, among others.

Throughout the event, the Impact Forum will host some of the world’s most creative thinkers to engage in uncommon conversations for extraordinary times including a dynamic mix of government and policy leaders, physicians and healthcare pioneers, prolific academics, technology visionaries from Fortune 50 companies to the world’s most promising start-ups, professional athletes and entertainers, CEOs and C-Suite executives and more.

This year’s program will feature discussions on topics hugely relevant to today’s industry leaders, including climate change and public health, brain health, health equity for children and women, cancer prevention, food as medicine and more.

Among the dozens of conversations taking place throughout the event, a few of the key panel discussions will include:


  • Remarkable Women Leading Global Change: Championing female leaders responsible for breakthroughs in their industries, the panel features Dr. Chelsea Clinton, Vice Chair, Clinton Foundation and Vice Chair, Clinton Health Access Initiative; Lauren Bush Lauren, Founder and Chief Brand Officer, FEED; and Noor Sweid, Managing Partner, Global Ventures; moderated by Alyson Shontell, Editor-in-Chief and CCO, Fortune Media.
  • The Repercussions of Healthcare on Climate Change: Setting national policy and global standards around the decarbonization of healthcare will be discussed by Dr. Victor Dzau, President, National Academy of Medicine; Dr. Rachel Levine, Admiral, U.S. Public Health Service, Assistant Secretary for Health, U.S. Department of Health and Human Services; George Barrett, Founder, The Overtone Group; and Dr. Jonathan Perlin, President and CEO, The Joint Commission; moderated by returning speaker Juju Chang, Emmy® Award-winning Co-Anchor, ABC News’ “Nightline.”
  • Psychedelics: The Trip of Our Lifetime: From the world’s foremost researchers on psychedelic medicine, promising findings on profound mental health conditions in this category will be shared by Dr. Rick Doblin, Founder and Executive Director, MAPS – Multidisciplinary Association for Psychedelic Studies; Dr. Rachel Yehuda, Director, Center for Psychedelic Psychotherapy and Trauma Research, Icahn School of Medicine at Mount Sinai; Dr. Robin Carhart-Harris, Ralph Metzner Distinguished Professor, Neurology and Psychiatry and Director, Psychedelics Division, Neuroscape, The University of California San Francisco; Paul Stamets, Mycologist, Inventor, Author, Entrepreneur, Earthling; and returning speaker Dr. Deepak Chopra, Co-Founder, The Chopra Foundation; Chairman, Chopra Global.

Fittingly, Lake Nona Impact Forum takes place within the living lab of Lake Nona where the latest technologies and innovative solutions are tested in a real-world environment every day. Purposefully planned to support healthy living, Lake Nona epitomizes an ecosystem of wellbeing with a medically-integrated sports and performance center, vibrant public art program, robust events calendar and miles of trails and dozens of parks anchored by a preeminent health and life sciences cluster. Thanks to the Impact Forum and the community’s unique focus on health, Lake Nona has attracted some of the world’s leading health and life sciences companies including Johnson & Johnson, Fountain Life, Chopra Global and Chopra Foundation, Limitless Minds, Hughston Clinic, HCA Healthcare, GuideWell Innovation, the University of Central Florida, the U.S. Department of Veterans Affairs and more.

“Since its inception 11 years ago, Lake Nona Impact Forum’s North Star is to inspire human potential through health and wellbeing innovation,” said Lake Nona Impact Forum Founder Gloria Caulfield. “As the meaning of wellbeing has evolved so have the discussions and luminaries we host, from the effects of the healthcare sector on climate change to the potential benefits of psychedelic therapy for mental health. Our long-term goal is to be an incubator that accelerates health and wellbeing innovation and sparks global change needed for public health, health systems and beyond.”

Click here for more details on all 2023 Impact Forum speakers and panelists.

The 2023 Lake Nona Impact Forum is presented by KPMG. Additional event supporters include Verizon, Fortune, Worth, Akkad Holdings, Chopra Foundation, GuideWell Innovation, AdventHealth, Citibank, Edyth Bush Charitable Foundation, Fountain Life, HCA Healthcare, Hughston Clinic, Integrated Wellness Partners, Leviton, Maximus, Microsoft, Garcia Stromberg, Myndstream, Labcorp and the Harvard T.H. Chan School of Public Health.

To learn more about the Impact Forum, visit http://www.LakeNonaImpactForum.org. Follow along with the Impact Forum on LinkedIn, Twitter and Instagram. You can also join the conversation online using the hashtag #LNIF23.

###

About Lake Nona Impact Forum:

For the past decade, Lake Nona has hosted a bespoke event, convening extraordinary health and innovation leaders at the annual Lake Nona Impact Forum. The Impact Forum has established a world class and intimate environment where C-Suite executives, prolific entrepreneurs, technology mavericks, health system/health plan CEOs, investors, and wellness experts can have stimulating, important conversations. The Impact Forum content is curated by a National Advisory Board comprised of world-renowned thought leaders from business, academia, government, the arts and industry who are heading the search for creative, innovative health and wellness solutions. This private health innovation retreat is reserved for 400 hand-selected delegates who can contribute, inspire and make changes to health.

For more information, visit http://www.LakeNonaImpactForum.org.

About Lake Nona:

Planned and developed by the Tavistock Group, Lake Nona is one of the fastest growing and most innovative communities in America. Located in Orlando, Florida, the 17-square-mile community has established a new standard of living for its residents with groundbreaking initiatives around technology, mobility, and wellbeing. Lake Nona is located contiguous to Orlando International Airport in the most visited destination in the U.S. The smart and connected community’s advanced infrastructure and commitment to collaboration has drawn visionary companies and entrepreneurs from across the globe to join its living lab environment accelerating economic growth and opportunity across health and life sciences, education, hospitality, and sports and performance. Lake Nona’s attractive business ecosystem is enhanced by a thriving cultural landscape defined by iconic architecture and engaging public art installations, miles of trails and walkable green spaces, weekly signature events, shopping, dining and entertainment options set amongst Central Florida’s beautiful natural landscape and year-round sunshine.

For more information, visit http://www.lakenona.com.



Flourish Medical Names Joanne Rupprecht CEO, Focusing on Women’s Health Med Device


Flourish Medical, a medical device development and manufacturing company dedicated to meeting the needs of the women’s health market, has named Joanne Rupprecht CEO.

Joanne Rupprecht, CEO of Flourish Medical

Joanne Rupprecht knows the healthcare space inside and out, how to work with complex regulatory requirements and how to get products to market as quickly as possible.

Flourish Medical, LLC, a medical device development and manufacturing company, has named Joanne Rupprecht CEO.

Flourish, dedicated to meeting the needs of the women’s health market, is the designer and manufacturer of a novel, single-use, disposable device that helps women manage stress urinary incontinence. Affecting more than 15 million women in the United States alone, stress incontinence is a condition that can affect women in many stages of life, and is the most common form of urinary incontinence.

“Jo brings a real understanding of medical device development to Flourish,” says Jim Kasic, chairman of the board for Flourish. “She knows the healthcare space inside and out, how to work with complex regulatory requirements and how to get products to market as quickly as possible.”

Rupprecht brings more than 35 years of medical device product development experience to Flourish. She started her career at Abbott Laboratories, and has become a recognized leader in healthcare product commercialization with extensive experience in entrepreneurship, law, compliance and ethics, and regulatory affairs and quality assurance.

The CEO also is a dedicated academician. She is an adjunct professor in the master’s program in biomedical entrepreneurship and regulatory affairs at the University of Colorado Denver, Anschutz Medical Campus, and serves as a member of the board of directors for the school’s Broadening Experiences in Scientific and Scholarly Training program. She also has held research integrity and regulatory affairs management positions at Colorado State University. Additional experience includes service as a legislative research fellow for the State of Colorado General Assembly.

The CEO holds a Bachelor of Science degree from the University of Illinois, and a Juris Doctor degree from the University of Denver Sturm College of Law. She is the recipient of the Colorado Bioscience Association’s 2021 Institute Leadership Award.

“The Flourish device means a positive lifestyle change for millions of women,” says Rupprecht. Research shows that fewer than 25% of women with incontinence seek medical advice or help for their problem, she explains, and that many of them do not want surgery or other invasive procedures. “Flourish provides the opportunity for these women to take control over this condition, manage their own situation and engage in daily activities without limitation, worry, or embarrassment,” she states. “It allows them to flourish and get back to the activities that bring them joy and fulfillment.”

Flourish Medical, LLC (http://www.flourish-medical.com)

Flourish Medical, LLC, is a medical device development and manufacturing company serving the needs of the women’s health market. The company’s flagship product, Flourish, is a novel, single-use, disposable device that helps women manage stress urinary incontinence. Flourish Medical is based in Boulder, Colorado.

Share article on social media or email:

nano3Dprint Announces Collaboration with the Luskin Orthopaedic Institute for Children and Billi Research Lab


nano3Dprint, a next-generation additive manufacturing solutions provider, today announced that it has entered into a collaboration with the Billi Research Lab, whose objective is to improve patient quality of life by developing breakthrough technologies and solutions to address unmet clinical needs. The Billi Research Lab is supported by the Luskin Orthopaedic Institute for Children (LuskinOIC).

The collaboration will enable Dr. Billi and his team to utilize nano3print’s 3D printing technologies to build integrated microcontroller systems for sensor-embedded devices that will benefit children served by LuskinOIC. Some of the devices currently under development include scoliosis braces, smart casts and Ponseti braces, which are used to treat clubfoot.

“We’re looking forward to utilizing nano3Dprint’s B3300 Dual-Dispensing 3D Printer to further our research and development of wearables, fusion sensors and smart textiles. Current additive technologies are not versatile enough to allow us to build the complex, multifunctional devices required to provide modern and truly disruptive healthcare,” said Dr. Fabrizio Billi, Director of the Musculoskeletal Devices and Technologies Development Group.

The Billi Research Lab’s smart cast project will, among other things, deliver real-time details about the fracture healing process, providing early warning of compartment syndrome, a dangerous condition in which swelling inside the cast limits blood flow to the limb, thereby causing tissue necrosis.

nano3Dprint’s B3300 will be used to 3D print the smart cast’s electronic package, including sensors that are printed directly on supports easily embeddable in the cast structure. The 3D printed circuits and sensors will allow complete integration and intelligent distribution of battery and wiring, eliminating the need for external wiring and obtrusive components. Moreover, the embedded circuit will allow for the connection of a multitude of sensors where necessary.

Dr. Billi added that a similar system could be made for the Ponseti brace with an electronics bar attached to – or replacing – the bar that connects the shoes. Similar electronics could be integrated into the “ribs” of an advanced scoliosis brace.

Dr. Billi and his team also hope to 3D print sensors directly on living tissues like bone, cartilage, tendons, and skin in a process already in progress and which has shown promise. “Monitoring mechanical and physiological parameters directly on the tissue would allow our team to significantly advance our understanding of health status and tissue response to treatment,” said Dr. Billi. “More importantly, they will be able to obtain the necessary biofeedback to move from developing therapeutic devices to developing theranostic devices.”

Ramsey Stevens, nano3Dprint CEO, said that the collaboration supports the company’s goals of advancing medicine through new technologies. “We’re excited to collaborate with Dr. Billi as he pioneers new medical devices to enhance patient care. One of our primary objectives is to improve research and development via multi-material 3D printing that ultimately leads to improvements across many sectors,” Stevens said.

For additional information, visit nano3Dprint at https://nano3dprint.com.

About nano3Dprint:

nano3Dprint offers next-generation additive manufacturing solutions that enable printing of fully-realized electronic devices with seamless integration of micro-to-nanoscale materials. With its electronics printer lineup, nano3Dprint is upleveling legacy 3D printing systems to allow users to invent, design, test, research and manufacture rapidly, easily and accurately.

About Luskin Orthopaedic Institute for Children:

Founded in 1911 as Los Angeles Orthopaedic Hospital, Luskin Orthopaedic Institute for Children (LuskinOIC) is solely focused on pediatric musculoskeletal orthopedics. Its mission is to provide outstanding care for patients with musculoskeletal disorders and through the support of the Luskin Orthopaedic Institute for Children Foundation, to provide care for children regardless of ability to pay and advance care worldwide for all musculoskeletal patients through medical education and scientific research.

About Billi Research Lab:

The Billi Research Lab is led by Dr. Fabrizio Billi, Director, Co-Director, Orthopaedic Research at Harbor-UCLA Medical Center. Its mission is to improve the quality of life of patients by developing breakthrough technologies and solutions to address unmet clinical needs.

Share article on social media or email:

The New York Times Highlights Discovery of a Healthy Fat to Slow Aging


This week, a New York Times-featured science article included the discovery of a healthy fat that may help slow down aging. This surprising finding was made by a veterinary epidemiologist while studying how to improve the health and well-being of Navy dolphins.

The New York Times article, by Emily Anthes, focuses on what dolphins–fellow large-brained and long-lived mammals–can teach us about human aging. The piece highlights Dr. Stephanie Venn-Watson’s decades-long research on why different groups of Navy dolphins had different rates of aging. Importantly, she and her team were able to reverse a key biomarker of aging by increasing dolphins’ dietary intake of C15:0, a newly discovered essential odd-chain saturated fatty acid.

“We are thrilled to see this important discovery included in The New York Times, one of the world’s leading sources for groundbreaking science news,” said Dr. Stephanie Venn-Watson, co-founder and CEO of Seraphina Therapeutics. “While we all know people who seem to age faster than others,” said Dr. Venn-Watson, “the dolphins not only helped to confirm this phenomenon, but they also unlocked the secret of how we could actively slow down the aging process.”

In 2020, Dr. Venn-Watson’s peer-reviewed study published in the Proceedings of the National Academy of Sciences showed that a key biomarker––hemoglobin––could be used to identify slow and fast aging dolphins; fast aging dolphins saw a steady decline in hemoglobin over their lifetime, while slow aging dolphins held relatively stable hemoglobin, even into their oldest years.

In humans, low hemoglobin is routinely used by physicians to detect anemia of aging, which affects more than 1-in-10 people over 60 years old, and 40% of these cases remain unexplained. Since hemoglobin in red blood cells is needed to deliver oxygen from our lungs to our tissues, this biomarker of fast and slow aging holds clinically relevant significance.

Dr. Venn-Watson then discovered that a diet containing higher amounts of C15:0 actually improved hemoglobin in dolphins. As published in PLOS ONE, elevated C15:0 levels effectively alleviated chronic anemia in fast aging dolphins. Dr. Venn-Watson went on to show that pure C15:0 supplementation had this same meaningful effect of raising hemoglobin and treating anemia in relevant models.

“These studies suggest that nutritional factors influencing aging rate biomarkers, including declining hemoglobin and anemia, may be targeted to delay the effects of aging in a compelling and relevant population,” said Dr. Nicholas Schork, a leader in longevity and co-author of the PNAS paper.

The science supporting C15:0’s potential to slow down aging has been mounting since Dr. Venn-Watson’s initial discoveries. Typically, the aging process is defined by nine “hallmarks of aging”, and pure C15:0 has been shown to directly address at least four of these hallmarks.

Specifically, C15:0 is able to address hallmarks of aging by:

  • Increasing cellular stability and repairing mitochondrial function to reverse age-related breakdown
  • Improving cellular signaling by naturally activating receptors called PPAR alpha and delta, which balance metabolism and immunity
  • Serving as an HDAC inhibitor, which can help repair damaged DNA and stop proliferation of cancerous cells

The many demonstrated age-slowing benefits of C15:0 have culminated in the recognition of C15:0 as the first essential fatty acid to be found since omega-3, which was over 90 years ago. The essentiality of C15:0 is underlined by numerous studies now linking higher C15:0 levels to lower risks of type 2 diabetes, heart disease, and nonalcoholic fatty liver disease. When compared to the purest, highest performing omega-3 (EPA), C15:0 demonstrated three times more cellular benefits and repaired more cell types. This latest study, which also showed that C15:0 has relevant antidepressant, antimicrobial, and anticancer activities, suggests that C15:0 may be the essential, essential fatty acid.

“Our decades-long journey, from helping dolphins age healthier to discovering C15:0 as an essential fatty acid to slow aging, is rapidly gaining momentum. And urgency,” said Dr. Venn-Watson.

A growing body of science now supports that nutritional C15:0 deficiencies may be driving the global rise in cardiometabolic conditions, including type 2 diabetes and NAFLD, a liver condition that affects 1 in 3 people globally. The rise in NAFLD has been particularly alarming due to this disease’s causal role in liver cirrhosis and cancer. NAFLD is rapidly becoming the leading cause of liver transplants globally.

“While observed age-related declines in C15:0 levels have been concerning, the good news is that these deficiencies can be fixed,” said Dr. Venn-Watson. “With the recent New York Times story, our movement to improve global health – one person and dolphin at a time – is well underway.”

The New York Times article can be read in full here.

Share article on social media or email:

FastWave Medical Announces IVL Utility Patent Granted From USPTO to Treat Cardiovascular Calcium


News Image

“Receiving a non-provisional utility patent, with broad claim sets, for our novel IVL system in just six months is truly impressive.”

FastWave Medical, a privately held company incubated by partners of Big Sky Biomedical, announced today it has been awarded a utility patent from the USPTO. FastWave Medical is rapidly developing intravascular lithotripsy (IVL) systems that are procedurally-efficient and cost-effective. The company is poised to disrupt this $9 billion addressable market with a novel solution for peripheral and coronary artery calcification (CAC).

“I am beyond thrilled that our fast-moving team has achieved this significant milestone. Receiving a non-provisional utility patent, with broad claim sets, for our novel IVL system in just six months is truly impressive,” said Scott Nelson, Chief Executive Officer and Co-Founder of FastWave Medical. “Cardiovascular calcium is complex to treat and there is a significant need for new interventional procedures; our system increases procedural efficiency and provides a more user-friendly experience to address this multi-billion dollar market.”

CAC is present in 90% of men and 67% of women older than the age of 70. While there have been advancements in CAC therapeutic options over the last few decades, global cardiovascular disease is on the rise and there remains an unmet need for improved technologies to treat calcific arterial plaque. Existing interventions can be costly and cumbersome to use, and many procedures come with an increased risk of adverse events. FastWave’s IVL systems are minimally-invasive and improve upon current offerings through enhanced catheter crossability, upgraded durability, and overall ease of use.

“Our incredible team has deep interventional vascular expertise, which has allowed us to achieve milestones with exceptional speed. A non-provisional utility patent granted this fast is virtually unheard of in the medical device industry,” said Tristan Tieso, Chief Operating Officer of FastWave Medical. “Our IVL systems offer clear differentiation versus other devices on the market and I couldn’t be more proud of the progress our strong group of engineers and technicians have made over the last year.”

About FastWave Medical Inc.

FastWave Medical, a privately held company incubated by partners of Big Sky Biomedical, is focused on developing intravascular lithotripsy (IVL) systems for calcific artery disease that are procedurally efficient and cost-effective. To learn more about FastWave Medical, please visit https://fastwavemedical.com.

About Big Sky Biomedical, LLC

Founded by a group of medical device serial entrepreneurs with extensive expertise in the vascular space, Big Sky Biomedical is a highly specialized accelerator focused on rapid, capital-efficient therapy development. To learn more about Big Sky Biomedical, please visit https://bigskybiomedical.com.

Media Contact

media@fastwavemedical.com

Share article on social media or email:

FANG CONSULTING ASSISTS THERMASOLUTIONS TO GAIN 510(k) AUTHORIZATION FOR NEW DEVICE


Fang Consulting Logo

“Without the regulatory support that Fang Consulting provided, we would not have been able to obtain 510(k) authorization from the FDA with only one round of questions that we were able to clear up in fifteen minutes,” Gregg Giza, Global Product Director of ThermaSolutions said.

Fang Consulting is extremely happy to announce that it has assisted ThermaSolutions in receiving 510(k) authorization for their new HurriChem device.

ThermaSolutions developed the HurriChem, a unique aerosolization tool used in abdominal surgery procedures.

Our team at Fang Consulting helped organize the 510(k) submission resulting in the HurriChem device receiving authorization with only one request for additional information from the FDA, to clarify three simple questions.

ThermaSolutions, based in St. Paul, Minnesota, is the global leader in Hyperthermic Intraperitoneal Chemotherapy Technology. ThermaSolutions has been developing innovative medical devices since 1999, seeing their experienced team grow to 20 people as of early 2023.

“Without the regulatory support that Fang Consulting provided, we would not have been able to obtain 510(k) authorization from the FDA with only one round of questions that we were able to clear up in fifteen minutes,” Gregg Giza, Global Product Director of ThermaSolutions said.

Fang Consulting is a Regulatory Affairs and Engineering Services company based out of Roseville, Minnesota specializing in medical device consulting. Since 1999, Fang has helped countless companies navigate the complicated regulatory affairs processes in getting medical devices authorized by the FDA.

Contact us at 612.230.9909 to learn more and see if our consulting services can help your company with any FDA related issues.

Contact Gregg Giza, ThermaSolutions’ Global Product Director at 612.968.0454 to learn more about their Hyperthermic Medical Technologies and if the HurriChem device or any others could be a solution for your business.

Share article on social media or email:

ProLiteracy’s New Issue of Research Journal Includes Forum on Mental Health


Research journal cover with title Adult Literacy Education The International Journal of Literacy, Language, and Numeracy

ProLiteracy has just released Volume 5, Issue 1 of it’s free research journal.

“At a time when conversations about mental health are becoming more open and common, the articles in the Forum are a welcome and relevant resource for tutors and instructors.”

ProLiteracy, which is dedicated to serving the adult literacy and education field by providing approachable and actionable research free of charge, has released Volume 5, Issue 1, of Adult Literacy Education: The International Journal of Literacy, Language, and Numeracy.

Of note in the Winter 2023 issue, the Forum section focuses on mental health and adult learners. The three articles in this section discuss the prevalence of mental illness among the low-literate adult population in America, how mental health disorders affect these adults and their learning, and how to support these students, including some who may have suffered past trauma. Tips and classroom strategies outlined in the Forum will give practitioners a better understanding of how to serve every adult in their programs regardless of their situation.

“At a time when conversations about mental health are becoming more open and common, the articles in the Forum are a welcome and relevant resource for tutors and instructors,” said Mark Vineis, ProLiteracy president and CEO.

In addition to the Forum, the new issue of the journal includes the two research articles “Age, Period, and Cohort Effects on Adult Literacy Skills in the United States” and “Community-Based Adult Learning: A Scottish Case Study in the Time of COVID-19.” A Report from the Field titled “An Intelligent Tutoring System for Adult Literacy Learners: Lessons for Practitioners” describes the development and implementation of a web-based intelligent tutoring system for adults reading at elementary levels. And the journal wraps up with book and resource reviews, a research digest, and the technology solutions column.

ProLiteracy produces Adult Literacy Education in partnership with Rutgers University. The journal editors—Alisa Belzer, Amy Rose, and Heather Brown—are respected researchers who believe research is an important complement to practitioners’ experiences, intuition, and professional training.

“Research can provide new ways of seeing things. It can raise new questions, new understandings, and new ways of doing things in the learning context,” Belzer said.

You can find the new issue of Adult Literacy Education at https://www.proliteracy.org/ALE-Journal. Writers interested in submitting articles for consideration in future issues of the journal can find author guidelines and a submission form on the journal’s webpage.

The online journal is published three times per year to share research and best practices in adult literacy, numeracy, and English language education with practitioners, policy makers, and funders. Each issue of Adult Literacy Education includes thought-provoking and peer-reviewed research articles written by leaders in the field to inform and frame wider conversations in the adult education field.

By keeping its research free, ProLiteracy ensures the important information shared in the journal can benefit all adult learners equally.

About ProLiteracy

ProLiteracy, the largest adult literacy and basic education organization in the nation, has been working for more than 60 years across the globe to change lives and communities through the power of literacy. Our organization provides support, professional development, resources, and digital tools to over 5,000 member and non-member programs across the U.S. and international partners in 27 countries, helping them support their adult learners.    

Share article on social media or email:

Dimension Inx Raises $12M Series A to Accelerate Commercialization of New Generation of Regenerative Therapeutics


Enabling a new generation of regenerative therapeutics, Dimension Inx’s platform engineers three-dimensional microenvironments that direct cell behavior and allow the body to restore tissue and organ function more effectively.

Dimension Inx, a biomaterials platform company, announced today that they have closed a $12M Series A Round. The round was led by Prime Movers Lab (PML), with participation by returning investors KdT Ventures and Revolution’s Rise of the Rest Seed Fund (ROTR). New investors participating in the round include Solas BioVentures, Portal Innovation Ventures, and Alumni Ventures.

Dimension Inx is a biomaterials platform that designs, develops, and manufactures therapeutic products. Enabling a new generation of regenerative therapeutics, Dimension Inx’s platform engineers three-dimensional microenvironments that direct cell behavior and allow the body to restore tissue and organ function more effectively.

The Chicago-based company will use the funding to advance the development of their therapeutics focused on functional organ restoration, and expand their manufacturing capabilities. In the near term, the company will use the funds to support the commercial launch of their first product, CMFlex™.

“We pride ourselves in catalyzing a step function change to unlock the full potential of regenerative therapeutics to cure complex disease, and we’re grateful to do so with the support of our investors,” stated CEO of Dimension Inx, Caralynn Nowinski Collens, M.D. “Our approach has always focused on the entire tissue microenvironment. If we provide the right blueprint, we make it possible to recruit the body’s natural strengths and accelerate the repair, regeneration, and ultimately, restoration of critical body function.”

“Dimension Inx represents the type of breakthrough science we believe will transform their industry and reshape our physical world,” said Prime Movers Lab Venture Partner Amy Kruse, Ph.D. who will be joining the company’s board. “We’re excited to support Dimension Inx as they enter this next phase of growth and development, and bring their transformative products to market.”

In addition to their Series A funding, Dimension Inx also announced that they have received U.S. Food and Drug Administration (FDA) 510(k) clearance for CMFlex™, the first 3D-printed regenerative bone graft product cleared by the FDA. As a ready-to-use flexible ceramic for oral and maxillo-facial indications, CMFlex improves clinician workflow and reduces surgical case time for clinicians, while restoring healthy bone.

“FDA clearance is a major milestone for our platform, and validates the work we’ve put into developing our product over the past two years,” said Dr. Collens. “CMFlex is a product that represents our unique approach to restoring functionality in the body: it’s a dynamic collaboration between biology, material composition, microstructure, and macroarchitecture. We’re excited by the interest we’ve already received from surgeons who recognize the importance of a ready-to-use solution that is easy to handle and accelerates healing to improve patient outcomes.”

To learn more about Dimension Inx and its platform, click here: http://www.dimensioninx.com.

ABOUT DIMENSION INX

Dimension Inx is a biomaterials platform company. We design and develop therapeutic products that restore tissue and organ function.

Our materials-centric approach enables biofunctionality without compromising manufacturability. We precisely tune our biomaterials to create clinical solutions not otherwise possible. We work shoulder-to-shoulder with biotech and medical device partners to help solve their most challenging materials problems, and internally develop medical products for various therapeutic applications ranging from bone regeneration to fertility preservation.

Dimension Inx is proudly based in Chicago, IL. To learn more about our team and our technology, please visit http://www.dimensioninx.com.

Dimension Inx. Biomaterials, reimagined.

ABOUT PRIME MOVERS LAB

Prime Movers Lab invests in breakthrough scientific startups founded by Prime Movers, the inventors who transform billions of lives. We invest in companies reinventing energy, transportation, infrastructure, manufacturing, agriculture and human augmentation. Portfolio investments span in-space transportation, industrial solar heat, ag tech, brain upgrades, nano-structured materials, wafer slicing, prosthetics, 3D printing, mobility, longevity and AI.

Share article on social media or email:

Creating Healthier Communities Announces New President and CEO Jean C. Accius, PhD


CHC New President and CEO Jean C. Accius, PhD

“This is an era of unprecedented opportunity, and I look forward to continuing to grow CHC’s impact, relevance and revenue,” said Dr. Jean C. Accius.

CHC: Creating Healthier Communities, a national nonprofit that removes the barriers to good health and equity, today announced Jean C. Accius, PhD as its new president and CEO.

“After an extensive search over the past six months with an abundance of incredibly strong candidates, we’re proud to welcome Dr. Jean Accius as CHC’s new president and CEO,” said Adam Rothschild, CHC board chair.

Dr. Accius previously served as Senior Vice President of Global Thought Leadership for AARP, the nation’s largest nonprofit advocating for solutions that advance equity and foster greater health security so everyone can live longer and healthier lives. Accius was instrumental in establishing AARP as a global convener and thought leader, elevating bold solutions and innovative programs, and forming strategic partnerships across industries to scale for impact and accelerate the pace of change. Prior to that, he held other senior roles at AARP and the Centers for Medicare & Medicaid Services.

“I was drawn to CHC’s powerful mission and dedicated board and staff team,” said Dr. Jean C. Accius. “It’s an incredible honor to join CHC at this significant time, just as the organization has completed a successful evolution to health equity. This is an era of unprecedented opportunity, and I look forward to continuing to grow CHC’s impact, relevance, and revenue. Together, we’ll break down the barriers to good health and equity and create resilient communities where everyone can thrive.”

“Leading CHC has been the highlight of my 40-year nonprofit career,” said Thomas G. Bognanno, president and CEO at CHC. “As I retire, I couldn’t be prouder of our board of directors and staff team and what we’ve accomplished together at CHC. I’m excited to welcome Jean as CHC’s new leader and am confident he will take our organization to new heights as we enter our seventh decade addressing critical health issues and advancing health equity.”

“We were fortunate to have such consistent, steady leadership from Tom who served CHC faithfully before announcing his retirement,” said Rothschild. “This enabled us to work together through an intentional succession process that will ensure CHC continues to flourish. Jean is an inspiring, impactful leader, personally and professionally dedicated to our mission. I’m incredibly grateful to Kevin Clayton, CHC’s former board chair and the head of social impact and equity at the Cleveland Cavaliers for leading the Board Search Committee. This successful appointment was a unanimous decision and is a testament to the committee’s integrity and diligence throughout the process.”

Accius has published numerous journal articles and research reports and is a sought-after speaker and presenter. His impressive educational credentials include a Doctor of Philosophy in Public Administration from American University; Master of Science in Aging Studies, Social Gerontology from Florida State University; Bachelor of Science in Business Administration also from Florida State University; as well as various certifications and Executive Education from notable institutions including Stanford Graduate School of Business, Georgetown McDonough School of Business, Harvard University School of Public Health and more. Accius is a certified director with the National Association of Corporate Directors and a fellow with the Executive Leadership Council.

His official start date will be Monday, February 27, including joining that week’s CHC Board of Directors meeting. To ensure a smooth transition and demonstrate his full support for the new CEO, current CEO Thomas G. Bognanno will remain with CHC through March 31.

ABOUT CHC: CREATING HEALTHIER COMMUNITIES

CHC: Creating Healthier Communities brings nonprofits, businesses, and communities together to improve community health. Our focus is health equity, addressing underlying issues and removing barriers so everyone can thrive. Our work is driven by community needs, and we direct programs, resources, and support where they have the greatest impact. Together with partners, we’ve been creating healthier communities for more than 65 years. Join us at chcimpact.org or @chcimpact.

Share article on social media or email:

SignatureCare Emergency Center’s ‘Stronger Together’ Mural Captures the Spirit and Resiliency of the Community


SignatureCare Emergency Center Mural at 3209 Montrose Blvd., Houston, TX 77006

SignatureCare Emergency Center Mural at 3209 Montrose Blvd., Houston, TX 77006

The mural was designed for the community. We want them to admire and enjoy it. That is exactly why we created it so the community can enjoy it.

SignatureCare Emergency Center has unveiled a mural aimed at honoring Houstonians and the company’s employees who worked tirelessly in the last few years to help their communities weather the effects of COVID and medical challenges.

Called ‘Stronger Together,’ the mural was created by Houston Muralist Sebastien Boileau and can be seen on the side of SignatureCare Emergency Center ER in Montrose, Houston, TX, at 3209 Montrose Blvd., Houston, TX 77006 (Google Map).

Mr. Boileau said he created the beautiful mural to show the strength of Houston residents and the diversity that makes the city of Houston special.

This mural “represents the strength that Houstonians can display towards each other during tough times but also the beautiful diversity that makes this city so special,” he said in Houston, TX.

Dr. Christopher Langan, MD, an Emergency Medicine Physician and Chief Operating Officer (COO) of SignatureCare Emergency Center said the mural is an effort to show the company’s appreciation to the community, for choosing SignatureCare for all their family’s emergency medical needs.

“For nearly a decade, the community chose SignatureCare Emergency Center as the ER they go to for all their family’s medical emergencies. We want to show them that we appreciate them so much,” he said.

Dr. Langan said that these last few years have been tough for the community with COVID and other emergencies but the community stood strong together.

“These last few years were not easy on anyone bit it has been wonderful to see the community come together time and again when the situation called for us to come together. We as a community are resilient and strong,’ he added.

He urged Houstonians to stop by and enjoy the mural anytime they are around Montrose or in Downtown Houston area.

“The mural was designed for the community. It’s like an icon in the center of our city of Houston. We want them to admire and enjoy it. That is exactly why we created it so the community can enjoy it,” he said.

About SignatureCare Emergency Center

Houston, TX-based SignatureCare Emergency Center owns 24-hour emergency centers throughout Texas, including Atascocita/Humble, Killeen, Austin, College Station/Bryan, Paris, Midland, Odessa, Texarkana, Spring, and Lewisville, TX. We also have nine ER locations in the Houston area, including in Montrose, Houston Heights, Cypress/FM 1960, Copperfield, Memorial City, Westchase, Bellaire, Mission Bend/Sugar Land, and Stafford.

Share article on social media or email: